Grace Medical, Inc. – Trademark Portfolio

Entity Type: 03

Grace Medical, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include G+, ALTO, TRIUNE, APOLLOS, and ECLIPSE. The owner is based in Memphis, TN.

8500 Wolf Lake Drive, Suite 110

Memphis, TN 38133

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Grace Medical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (12 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Grace Medical, Inc. have?

Grace Medical, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 11 registered, 1 abandoned.

What trademark classes does Grace Medical, Inc. file in?

Grace Medical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Grace Medical, Inc.'s most well-known trademarks?

Grace Medical, Inc.'s registered trademark portfolio includes well-known marks such as G+, ALTO, TRIUNE, APOLLOS, and ECLIPSE. These are among 11 currently registered trademarks in the portfolio.

What is Grace Medical, Inc.'s trademark registration success rate?

Grace Medical, Inc. has a 92% trademark registration rate, with 11 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.